KENDRA POWERS: Open Payments
NPI 1093331670 · VIRGINIA BEACH, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$619 in 35 payments from 8 companies in 2025. Trend: 2023 $696 · 2024 $901 · 2025 $619
Food & beverage: $619
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $209 |
| AstraZeneca Pharmaceuticals LP | 6 | $100 |
| Lilly USA, LLC | 6 | $90 |
| Novo Nordisk Inc | 4 | $84 |
| PFIZER INC. | 3 | $65 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $34 |
| GlaxoSmithKline, LLC. | 1 | $23 |
| Amgen Inc. | 1 | $14 |
Products named: VRAYLAR, UBRELVY, MOUNJARO, AIRSUPRA, Ozempic, NURTEC ODT, XIFAXAN, TRELEGY ELLIPTA.
Industry payments across VA — which companies pay providers there.
